Skip to content
Open in App
WuXi Biologics logo

WuXi Biologics

web2

WuXi Biologics (Cayman) Inc., an investment holding company, provides end-to-end solutions and...

Symbol · WXIBF
Company profile

About

WuXi Biologics (Cayman) Inc., an investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, Australia, and Brazil. It operates through two segments: Biologics and XDC. The company provides a suite of solutions for biologic discovery, from concept to IND, that seamlessly transits to CMC and downstream process development through its contract research, development, and manufacturing organization platforms, including WuXiBody, SDArBodY, T cell engager, Tumor Associated Antigens (“TAA”) mAb Technology, Single B Cell Cloning Technology, WuXia, WuXiUP, WuXiUI, and WuXiHigh. It engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, production and sales of medicals, and biologics clinical and manufacturing services; research and development in relation to biologics; international sales contracting service; vaccine contract development and manufacturing organization (CDMO) and related business; development, production, and distribution of biotechnological products; and engages in investment and material supplier activities. WuXi Biologics (Cayman) Inc. was incorporated in 2014 and is headquartered in Wuxi, China.

Explore by sector

Explore this sector

Market identity

Exchange listings

Listing identities only. Orbitrum does not publish live prices or market performance on this public profile.

People

Company team

GL

Ge Li

Founder & Chairman

Company leadership profile.

ZC

Zhisheng Chen

CEO & Executive Director

Company leadership profile.

XG

Xuejun Gu

CTO, Chief Client Officer, EVP of Global Biologics Development Department & Executive Director

Company leadership profile.

WR

William Robert Keller

Independent Non-Executive Director

Company leadership profile.

JP

Jackson Peter Tai

Independent Non-Executive Director

Company leadership profile.

YC

Yanling Cao

Non-Executive Director

Company leadership profile.

JW

James W. Larrick

Member of Scientific Advisory Board

Company leadership profile.

RS

Ram Sasisekharan

Member of Scientific Advisory Board

Company leadership profile.

DD

David D. Ho

Member of Scientific Advisory Board

Company leadership profile.

WH

Wei-Shou Hu

Member of Scientific Advisory Board

Company leadership profile.

KW

Kenneth Walton Hitchner

Independent Non-Executive Director

Company leadership profile.

RG

Rolf G. Werner

Member of Scientific Advisory Board

Company leadership profile.

JC

Jue Chen

Independent Non-Executive Director

Company leadership profile.

JM

Jingwen Miao

Non-Executive Director

Company leadership profile.

Expert coverage

1 expert evaluated WuXi Biologics.

Orbitrum research

Experts evaluating WuXi Biologics

Explore the public profiles of experts who have evaluated this project.

Orbitrum Academy

Learn how to read a project assessment